Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats

Life Sciences

Volumn 73, Issue 14, 2003, Pages 1813-1824

  Cotter, M A ^a   Cameron, N E ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Angiotensin II; In vitro; iNOS; Nitric oxide; Noradrenaline

Indexed keywords

ANTIOXIDANT; APOCYNIN; ENZYME INHIBITOR; HYDROGEN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL FUNCTION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEUROPATHY; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENCY; EXPERIMENTAL MODEL; HYDROGEN CLEARANCE; MALE; MICROELECTRODE; MOTOR NERVE CONDUCTION; NERVE FUNCTION; NONHUMAN; NUTRITION; PERIPHERAL NERVE; POLAROGRAPHY; RAT; REGULATORY MECHANISM; SAPHENOUS NERVE; SCIATIC NERVE; SENSORY NERVE; STREPTOZOCIN DIABETES; TISSUE PERFUSION;

EID: 0042848457     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00508-3     Document Type: Article

References (53)

1. Baynes J.W., Thorpe S.R. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes. 48:1999;1-9.
2. Bayraktutan U., Blayney L., Shah A.M. Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells. Arteriosclerosis Thrombosis and Vascular Biology. 20:2000;1903-1911.
3. Cai H., Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circulation Research. 87:2000;840-844.
4. Cameron N.E., Cotter M.A. Reversal of peripheral nerve conduction and perfusion deficits by the free radical scavenger, BM15.0639, in diabetic rats. Naunyn-Schmiedeberg's Archives of Pharmacology. 352:1995;685-690.
5. Cameron N.E., Cotter M.A. Rapid reversal by aminoguanidine of the neurovascular effects of diabetes in rats: modulation by nitric oxide synthase inhibition. Metabolism. 45:1996;1147-1152.
6. Cameron N.E., Cotter M.A. Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Diabetes Research and Clinical Practice. 45:1999;137-146.
7. Cameron N.E., Cotter M.A., Robertson S. The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats. Quarterly Journal of Experimental Physiology. 74:1989;917-926.
8. Cameron N.E., Cotter M.A., Low P.A. Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. American Journal of Physiology. 261:1991;E1-E8.
9. Cameron N.E., Cotter M.A., Archibald V., Dines K.C., Maxfield E.K. Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats. Diabetologia. 37:1994;449-459.
10. Cameron N.E., Cotter M.A., Dines K.C., Maxfield E.K., Carey F., Mirrlees D.J. Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: dose-response considerations and independence from a myo-inositol mechanism. Diabetologia. 37:1994;651-663.
11. Cameron N.E., Cotter M.A., Hohman T.C. Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats. Diabetologia. 39:1996;172-182.
12. +-ATPase activity and glutathione content in diabetic rats. Diabetologia. 42:1999;1120-1130.
13. Cameron N.E., Eaton S.E.M., Cotter M.A., Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia. 44:2001;1973-1988.
14. Cotter M.A., Jack A.M., Cameron N.E. Effects of the protein kinase C β-isoform inhibitor, LY333531, on neural and vascular function in streptozotocin-diabetic rats. Clinical Science. 103:2002;311-321.
15. Dodd-O J.M., Pearse D.B. Effect of the NADPH oxidase inhibitor apocynin on ischemia-reperfusion lung injury. American Journal of Physiology. 279:2000;H303-H312.
16. Du X.L., Stockklauser-Faber K., Rösen P. Generation of reactive oxygen intermediates, activation of NF-Kappa B, and induction of apoptosis in human endothelial cells by glucose: Role of nitric oxide synthase? Free Radical Biology and Medicine. 27:1999;752-763.
17. Ellis E.A., Grant M.B., Murray F.T., Wachowski M.B., Guberski D.L., Kubilis P.S., Lutty G.A. Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. Free Radical Biology and Medicine. 24:1998;111-120.
18. Forbes J.M., Cooper M.E., Thallas V., Burns W.C., Thomas M.C., Brammer G.C., Lee F., Grant S.L., Burrell L.A., Jerums G., Osicka T.M. Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic neuropathy. Diabetes. 51:2002;3274-3282.
19. Hink U., Li H., Mollnau H., Oelze M., Matheis E., Hartmann M., Skatchkov M., Thaiss F., Stahl R.A.K., Warnholtz A., Meinertz T., Griendling K., Harrison D.G., Forstermann U., Munzel T. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circulation Research. 88:2001;e14-e22.
20. Holland J.A., O'Donnell R.W., Chang M.M., Johnson D.K., Ziegler L.M. Endothelial cell oxidant production: Effect of NADPH oxidase inhibitors. Endothelium. 7:2000;109-119.
21. Inoguchi T., Li P., Umeda F., Yu H.Y., Kakimoto M., Imamura M., Aoki T., Etoh T., Hashimoto T., Naruse M., Sano H., Utsumi H., Nawata H. High glucose levels and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes. 49:2000;1939-1945.
22. Johnson D.K., Schiller K.J., Kwait D.M., Hughes C.V., McNamara E.J., Ishmael F., O'Donnell R.W., Chang M.M., Hogg M.G., Dordick J.S., Santhanam L., Ziegler L.M., Holland J.A. Inhibition of NADPH oxidase activation in endothelial cells by ortho-methoxy-substituted catechols. Endothelium. 9:2002;191-203.
23. Kashiwagi A., Shinozaki K., Nishio T., Okamura T., Toda N., Kikkawa R. Free radical production in endothelial cells as a pathogenetic factor for vascular dysfunction in the insulin resistant state. Diabetes Research and Clinical Practice. 45:1999;199-203.
24. Keegan A., Walbank H., Cotter M.A., Cameron N.E. Chronic vitamin E treatment prevents defective endothelium-dependent relaxation in diabetic rat aorta. Diabetologia. 38:1995;1475-1478.
25. Kihara M., Zollman P.J., Smithson I.L., Lagerlund T.D., Low P.A. Hypoxic effect of exogenous insulin on normal and diabetic peripheral nerve. American Journal of Physiology. 266:1994;E980-E985.
26. Kihara M., Low P.A. Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy. Experimental Neurology. 132:1995;180-185.
27. Kim Y.K., Lee M.S., Son S.M., Kim I.J., Lee W.S., Rhim B.Y., Hong K.W., Kim C.D. Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes. Diabetes. 51:2002;522-527.
28. Koya D., King G.L. Protein kinase C activation and the development of diabetic complications. Diabetes. 47:1998;859-866.
29. Kudo M., Nishikawa M., Ikeda H., Okubo T. Involvement of superoxide anions in ozone-induced airway hyperresponsiveness in unanaesthetized guinea pigs. Environmental Toxicology and Pharmacology. 2:1996;25-30.
30. Love A., Cotter M.A., Cameron N.E. Effects of α-tocopherol on nerve conduction velocity and regeneration following a freeze lesion in immature diabetic rats. Naunyn-Schmeideberg's Archives of Pharmacology. 355:1997;126-130.
31. Low P.A., Lagerlund T.D., McManis P.G. Nerve blood flow and oxygen delivery in normal, diabetic and ischemic neuropathy. International Review of Neurobiology. 31:1989;355-438.
32. Low P.A., Nickander K.K., Tritschler H.J. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes. 46(Suppl. 2):1997;S38-S42.
33. Malik R.A., Williamson S., Abbott C., Carrington A.L., Iqbal J., Schady W., Boulton A.J. Effect of the angiotensin converting enzyme inhibitor trandalopril on human diabetic neuropathy: a randomised controlled trial. Lancet. 352:1998;1978-1981.
34. 1 receptor antagonist. American Journal of Physiology. 269:1995;E530-E537.
35. Maxfield E.K., Cameron N.E., Cotter M.A. Effects of diabetes on reactivity of sciatic vasa nervorum in rats. Journal of Diabetes and its Complications. 11:1997;47-55.
36. Meyer J.W., Holland J.A., Ziegler L.M., Chang M.M., Beebe G., Schmitt M.E. Identification of a functional leukocyte-type NADPH oxidase in human endothelial cells: a potential atherogenic source of reactive oxygen species. Endothelium. 7:1999;11-22.
37. Nagamatsu M., Nickander K.K., Schmelzer J.D., Raya A., Wittrock D.A., Tritschler H., Low P.A. Lipoic acid improves nerve blood flow, reduces oxidative stress and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care. 18:1995;1160-1167.
38. Pagano P.J., Clark J.K., Cifuentes-Pagano M.E., Clark S.M., Callis G.M., Quinn M.T. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proceedings of the National Academy of Sciences of the United States of America. 94:1997;14483-14488.
39. Pieper G.M., Siebeneich W. Diabetes-induced endothelial dysfunction is prevented by long term treatment with the modified iron chelator, hydroxyethyl starch conjugated-deferoxamine. Journal of Cardiovascular Pharmacology. 30:1997;734-738.
40. Rösen P., Ballhausen T., Bloch W., Addicks K. Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: influence of tocopherol as antioxidant. Diabetologia. 38:1995;1157-1168.
41. Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B.A., Griendling K.K., Harrison D.G. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. Journal of Clinical Investigation. 97:1996;1916-1923.
42. Stolk J., Hiltermann T.J., Dijkman J.H., Verhoven A.J. Characteristics of the inhibition of NADPH oxidase activation in neurtophils by apocynin, a methoxy-substituted catechol. American Journal of Respiratory Cell and Molecular Biology. 11:1994;95-102.
43. Thart B.A., Elferink J.G., Nibbering P.H. Effect of apocynin on the induction of ulcerative lesions in rat skin injected with tubercle bacteria. International Journal of Immunopharmacology. 14:1992;953-961.
44. Timimi F.K., Ting H.H., Haley E.A., Roddy M.A., Ganz P., Creager M.A. Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Journal of the American College of Cardiology. 31:1998;552-557.
45. Traub O., Berk B.C. Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. Arteriosclerosis Thrombosis and Vascular Biology. 18:1998;677-685.
46. Tribe R.M., Thomas C.R., Poston L. Flow-induced dilatation in isolated arteries from control and streptozotocin-diabetic rats. Diabetologia. 41:1998;34-39.
47. Tuck R.R., Schmelzer J.D., Low P.A. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain. 107:1984;935-950.
48. Viedt C., Soto U., Krieger-Brauer H.I., Fei J., Elsing C., Kubler W., Kreuzer L. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species. Arteriosclerosis Thrombosis and Vascular Biology. 20:2000;940-948.
49. Wautier M.P., Chappey O., Corda S., Stern D.M., Schmidt A.M., Wautier J.L. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. American Journal of Physiology. 280:2001;E685-E691.
50. Weber C., Erl W., Pietsch A., Strobel M., Zieglerheitbrock H.W., Weber P.C. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-kappa-B mobilization and induction of vascular cell-adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arteriosclerosis Thrombosis and Vascular Biology. 14:1994;1665-1673.
51. Wingler K., Wunsch S., Kreutz R., Rothermund L., Paul M., Schmidt H.H. Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the rennin-angiotensin system in vitro and in vivo. Free Radical Biology and Medicine. 31:2001;1456-1464.
52. Wolff S.P. Diabetes mellitus and free radicals. British Medical Bulletin. 49:1995;642-652.
53. Zulueta J.J., Yu F.S., Hertig I.A., Thannickal V.J., Hassoun P.M. Release of hydrogen peroxide in response to hypoxia-reoxygenation: role of an NAD(P)H oxidase-like enzyme in endothelial cell plasma membrane. American Journal of Respiratory Cell and Molecular Biology. 12:1995;41-49.